Protective effects of trans-2, 4-dimethoxystibene on cognitive, impairments induced by Aβ25-35 in, hypercholesterolemic rats

Brain Research Bulletin

Volumn 82, Issue 5-6, 2010, Pages 251-258

  Ruan, Can Jun ^a   Li, Zhan ^b   Zhang, Li ^c   Chen, Di Hua ^b   Du, Guan Hua ^c   Sun, Lan ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

^c INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

A 25 35; Alzheimer's disease; Hypercholesterolemia; Neuroprotective; Oxidative; Stilbene

Indexed keywords

2,4 DIMETHOXYSTIBENE; ACETYLCHOLINE; ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN[25-35]; CHOLINE ACETYLTRANSFERASE; CYTOCHROME C; ESTRADIOL; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; STILBENE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; ACHE PROTEIN, RAT; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (25-35); GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; NEUROPROTECTIVE AGENT; PEPTIDE FRAGMENT; STILBENE DERIVATIVE; TRANS-2,4-DIMETHOXYSTIBENE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BEHAVIOR CHANGE; BRAIN LATERAL VENTRICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIPPOCAMPUS; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; MAZE TEST; NEUROPROTECTION; NEUROTOXICITY; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SPECTROPHOTOMETRY; TREATMENT OUTCOME; WESTERN BLOTTING; ANALYSIS OF VARIANCE; ANIMAL; CHEMICALLY INDUCED; COGNITION DISORDERS; DISEASE MODEL; DRUG EFFECTS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOMOTOR PERFORMANCE; REACTION TIME; TIME; WISTAR RAT;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; CHOLINE O-ACETYLTRANSFERASE; COGNITION DISORDERS; CYTOCHROMES C; DISEASE MODELS, ANIMAL; FEMALE; GLUTATHIONE PEROXIDASE; HIPPOCAMPUS; HYPERCHOLESTEROLEMIA; INJECTIONS, INTRAVENTRICULAR; MALONDIALDEHYDE; MAZE LEARNING; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; REACTION TIME; STILBENES; SUPEROXIDE DISMUTASE; TIME FACTORS; AMYLOID BETA-PEPTIDES; GPI-LINKED PROTEINS;

EID: 77955091026     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2010.04.016     Document Type: Article

References (38)

1. Arias C., Arrieta I., Tapia R. β-Amyloid peptide 25-35 potentiates the calcium-dependent release of excitatory amino acids from depolarized hippocampal slices. Journal of Neuroscience Research 1995, 41:561-566.
2. Arias C., Montiel T., Quiroz-Baóez R., Massieu L. β-Amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and in isolated nerve terminals: implications for Alzheimer's disease. Experimental Neurology 2002, 176:163-174.
3. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982, 2179:408-417.
4. Behl C. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches. Progress in Neurobiology 1999, 57:301-323.
5. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994, 77:817-827.
6. Bohacek J., Bearl A.M., Daniel J.M. Long-term ovarian hormone deprivation alters the ability of subsequent oestradiol replacement to regulate choline acetyltransferase protein levels in the hippocampus and prefrontal cortex of middle-aged rats. Journal of Neuroendocrinology 2008, 20(8):1023-1027.
7. Burns M.P., Noble W.J., Olm V., Gaynor K., Casey E., LaFrancois J., Wang L., Duff K. Co-localization of cholesterol, apolipoprotein E and fibrillar Aβ in amyloid plaques. Brain Research. Molecular Brain Research 2003, 110:119-125.
8. Butterfield D.A. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. Free Radical Research 2002, 36:1307-1313.
9. Butterfield D.A., Boyd-Kimball D. Amyloid β-peptide (1-42) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain. Brain Pathology 2004, 14:426-432.
10. Butterfield D.A., Lauderback C.M. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid β-peptide associated free radical oxidative stress. Free Radical Biology & Medicine 2002, 32:1050-1060.
11. DeKosky S.T., Harbaugh R.E., Schmitt F.A., Bakay R.A., Chui H.C., Knopman D.S., Reeder T.M., Shetter A.G., Senter H.J., Markesbery W.R. Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neurophthological, and cognitive correlations. Intraventricular bethanecol study group. Annals of Neurology 1992, 32:625-632.
12. Delobette S., Privat A., Maurice T. In vitro aggregation facilities betaamyloid peptide-(25-35)-induced amnesia in the rat. European Journal of Pharmacology 1997, 319:1-4.
13. Ghribi O., Larsen B., Schrag M., Herman M.M. High cholesterol content in neurons increases BACE, b-amyloid, and phosphorylated tau levels in rabbit hippocampus. Experimental Neurology 2006, 200:460-467.
14. Gonzalo R.A., Sanz J.M., Gonzalo P., Arévalo J., Gonzalo P. Amyloid beta peptide-induced cholinergic fibres loss in the cerebral cortex of rat is modified by diet high in lipids and by age. Journal of Chemical Neuroanatomy 2005, 29:31-48.
15. Grant W.B. Dietary links to Alzheimer's disease. Alzheimer's Disease Review 1997, 2:42-55.
16. Haeffner F., Smith D.G., Barnham K.J., Bush A.I. Model studies of cholesterol and ascorbate oxidation by copper complexes: relevance to Alzheimer's disease β-amyloid metallochemistry. Journal of Inorganic Biochemistry 2005, 99:2403-2422.
17. Heikkinen T., Puolivali J., Liu L., Rissanen A., Tanila H. Effects of ovariectomy and estrogen treatment on learning and hippocampal neurotransmitters in mice. Hormones and Behavior 2002, 41(1):22.
18. Heynekamp J.J., Weber W.M., Hunsaker L.A., Gonzales A.M., Orlando R.A., Deck L.M., Jagt D.L. Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB. Journal of Medicinal Chemistry 2006, 49:7182-7189.
19. Jarvik G.P., Austin M.A., Fabsitz R.R., Auwerx J., Reed T., Christian J.C., Deeb S. Genetic influences on age-related change in total cholesterol, low density lipoprotein-cholesterol, and triglyceride levels: longitudinal apolipoprotein E genotype effects. Genetic Epidemiology 1994, 11:375-384.
20. Jian-xun L., Wei-hong C., Liu X. effect of combination of extracts of ginseng and ginkgo biloa on acetylcholine in amyloid beta-protein-treated rats determined by an improved HPLC. Acta Pharmacologica Sinica 2004, 25:1118-1123.
21. Koudinov A.R., Berezov T.T., Koudinova N.V. The levels of soluble amyloid beta in different high density lipoprotein subfractions distinguish Alzheimer's and normal aging cerebrospinal fluid: implication for brain cholesterol pathology?. Neuroscience Letters 2001, 314:115-118.
22. Lehéricy S., Hirsch É., Cervera-Piérot P., Hersh L.B., Bakchine S., Piette F., Duyckaerts C., Hauw J.J., Javoy-Agid F., Agid Y. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. The Journal of Comparative Neurology 1993, 330:15-31.
23. Puglielli L., Tanzi R.E., Kovacs D.M. Alzheimer's disease: the cholesterol connection. Nature Neuroscience 2003, 6:345-351.
24. Mark R.J., Geddes J.W., Uchida K., Mattson M.P. Amyloid β peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. The Journal of Neuroscience 1997, 17:1646-1654.
25. D. Molho, J. Coillard. New methods of preparation of some stilbene derivatives. Bulletin de la Societe Chimique de France, 1956, pp. 78-93.
26. Moorthy K., Sharma D., Basir S.F., Baquer N.Z. Administration of estrodiol and progesterone modulate the activities of antioxidant enzyme an daminotransferase in naturally menopausal rats. Experimental Gerontology 2005, 40(4):295-302.
27. Mori T., Paris D., Town T., Rojiani A.M., Sparks D.L., Delledonne A., Crawford F., Abdullah L.I., Humphrey J.A., Dickson D.W., Mullan M.J. Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APP (SW) mice. Journal of Neuropathology & Experimental Neurology 2001, 60:778-785.
28. Nelson T.J., Alkon D.J. Oxidation of cholesterol by amyloid precursor protein and β-amyloid peptide. The Journal of Biological Chemistry 2005, 280:7377-7387.
29. 2. The Journal of Biological Chemistry 2002, 277:40302-40308.
30. Panza F., D'Introno A., Colacicco A.M., Capurso C., Pichichero G., Capurso S.A., Capurso A., Solfrizzi V. Lipid metabolism in cognitive decline and dementia. Brain Research Reviews 2006, 51:275-292.
31. Perry E.K., Tomlinson B.E., Blessed G., Bergmann K., Gibson P.H., Perry R.H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. British Medical Journal 1978, 2:1457-1459.
32. Refolo L.M., Malester B., LaFrancois J., Bryant-Thomas T., Wang R., Tint G.S., Sambamurti K., Duff K., Pappolla M.A. Hypercholesterolemic accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiology of Disease 2000, 7:321-331.
33. Tan Z.S., Seshadri S., Beiser A., Wilson P.W., Kiel D.P., Tocco M., D'Agostino R.B., Wolf P.A. Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Archives of Internal Medicine 2003, 163:1053-1057.
34. Vaya J., Schipper H.M. Oxysterols, cholesterol homeostasis, and Alzheimer disease. Journal of Neurochemistry 2007, 6:1727-1737.
35. Wilcock G.K., Esiri M.M., Bowen D.M., Smith C.C. Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. Journal of the Neurological Science 1982, 57:407-417.
36. Winkler J., Suhr S.T., Gage F.H., Thal L.J., Fisher L.J. Essential role of neocortical acetycholine in spatial memory. Nature 1995, 375:484-487.
37. Wolozin B. A fluid connection: cholesterol and Abeta. Proceedings of National Academy Science United States of America 2001, 98:5371-5373.
38. Yatin S.M., Varadarajan S., Link C.D., Butterfield D.A. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid β peptide (1-42). Neurobiology of Aging 1999, 20:325-330.